<span id="midArticle_start"/> (Reuters) - Denmark's Novo Nordisk saidthe U.S. Food and Drug Administration accepted a resubmittedapplication for its insulin drug, Tresiba.
<span id="midArticle_0"/>The drug, already available in Europe and other markets, wasrebuffed by the FDA two years ago on concerns that it could belinked with higher rates of heart attacks or strokes. (Reporting by Natalie Grover in Bengaluru; Editing by DonSebastian)
<span id="midArticle_1"/>
<span id="midArticle_0"/>The drug, already available in Europe and other markets, wasrebuffed by the FDA two years ago on concerns that it could belinked with higher rates of heart attacks or strokes. (Reporting by Natalie Grover in Bengaluru; Editing by DonSebastian)
<span id="midArticle_1"/>
via Smart Health Shop Forum http://ift.tt/1ybF2CX
No comments:
Post a Comment